Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "marketing"

908 News Found

Awshad launches Calmagummies Gold to tap cannabis-based wellness market
Healthcare | June 08, 2026

Awshad launches Calmagummies Gold to tap cannabis-based wellness market

Premium CBD+THC-infused gummies target stress relief, relaxation, and sleep recovery


Kaushik Deb elevated to Vice President at Mankind Pharma
People | June 05, 2026

Kaushik Deb elevated to Vice President at Mankind Pharma

Seasoned pharma leader recognized for driving sales excellence, marketing strategy, and business growth


Alembic appoints Ramesh Juneja as Executive Vice President – Human Health for India business
People | June 04, 2026

Alembic appoints Ramesh Juneja as Executive Vice President – Human Health for India business

Juneja brings more than three decades of experience in pharmaceutical sales and marketing


Marksans Pharma to acquire Netherlands-based QliniQ
News | June 02, 2026

Marksans Pharma to acquire Netherlands-based QliniQ

Acquisition provides direct access to the Dutch healthcare market, enhancing Marksans’ sales, distribution and market-access capabilities across regulated European markets


Wockhardt wins FDA nod for new antibiotic ZAYNICH against drug-resistant infections
Drug Approval | June 01, 2026

Wockhardt wins FDA nod for new antibiotic ZAYNICH against drug-resistant infections

The approval marks a major milestone in the global fight against antimicrobial resistance


Dr. Ramesh Juneja joins  Alembic Pharmaceuticals as Head – India Business
People | May 26, 2026

Dr. Ramesh Juneja joins Alembic Pharmaceuticals as Head – India Business

With over three decades of extensive industry experience, Ramesh Juneja brings a strong track record of building and scaling large businesses


EMA backs conditional EU nod for Vijoice in rare life-threatening overgrowth disorder PROS
News | May 26, 2026

EMA backs conditional EU nod for Vijoice in rare life-threatening overgrowth disorder PROS

The company is expected to conduct further studies to confirm the long-term efficacy and safety of Vijoice in both adult and paediatric patients


EMA accepts filing for Teva and Medincell’s long-acting schizophrenia treatment candidate
News | May 25, 2026

EMA accepts filing for Teva and Medincell’s long-acting schizophrenia treatment candidate

If approved, TEV-‘749 would mark a shift toward long-acting care aimed at improving treatment adherence in real-world settings


ZIM Laboratories wins European regulatory milestone with anticoagulant approval in Italy
News | May 23, 2026

ZIM Laboratories wins European regulatory milestone with anticoagulant approval in Italy

The approval was granted by Agenzia Italiana del Farmaco


Venus Remedies secures global approval for Plerixafor in Saudi Arabia
Drug Approval | May 22, 2026

Venus Remedies secures global approval for Plerixafor in Saudi Arabia

SFDA nod marks company’s strategic entry into high-value specialty oncology injectables as it targets expanding stem cell transplant and haemato-oncology market in the GCC region